DE60136688D1 - Partnern des ptb1 domäne aus fe65, herstellung und verwendungen davon - Google Patents

Partnern des ptb1 domäne aus fe65, herstellung und verwendungen davon

Info

Publication number
DE60136688D1
DE60136688D1 DE60136688T DE60136688T DE60136688D1 DE 60136688 D1 DE60136688 D1 DE 60136688D1 DE 60136688 T DE60136688 T DE 60136688T DE 60136688 T DE60136688 T DE 60136688T DE 60136688 D1 DE60136688 D1 DE 60136688D1
Authority
DE
Germany
Prior art keywords
partners
ptb1
dome
manufacture
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136688T
Other languages
English (en)
Inventor
Isabelle Maury
Luc Mercken
Alain Fournier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0001628A external-priority patent/FR2804962B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60136688D1 publication Critical patent/DE60136688D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Soft Magnetic Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE60136688T 2000-02-10 2001-02-07 Partnern des ptb1 domäne aus fe65, herstellung und verwendungen davon Expired - Lifetime DE60136688D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001628A FR2804962B1 (fr) 2000-02-10 2000-02-10 Partenaires du domaine ptb1 de fe65, preparation et utilisations
US19850000P 2000-04-18 2000-04-18
PCT/FR2001/000361 WO2001059104A1 (fr) 2000-02-10 2001-02-07 Partenaires du domaine ptb1 de fe65, preparation et utilisations

Publications (1)

Publication Number Publication Date
DE60136688D1 true DE60136688D1 (de) 2009-01-08

Family

ID=26212162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136688T Expired - Lifetime DE60136688D1 (de) 2000-02-10 2001-02-07 Partnern des ptb1 domäne aus fe65, herstellung und verwendungen davon

Country Status (17)

Country Link
US (2) US6696273B2 (de)
EP (1) EP1257642B1 (de)
KR (1) KR100802687B1 (de)
AT (1) ATE415476T1 (de)
AU (2) AU3562501A (de)
BR (1) BR0108247A (de)
CA (1) CA2399939A1 (de)
CY (1) CY1108758T1 (de)
DE (1) DE60136688D1 (de)
DK (1) DK1257642T3 (de)
ES (1) ES2315273T3 (de)
IL (1) IL151147A0 (de)
MX (1) MXPA02007620A (de)
NO (1) NO330798B1 (de)
NZ (1) NZ520697A (de)
PT (1) PT1257642E (de)
WO (1) WO2001059104A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146737A1 (de) * 2001-09-22 2003-04-10 Aventis Pharma Gmbh Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389526A (en) * 1989-11-02 1995-02-14 Slade; Martin B. Plasmid vectors for cellular slime moulds of the genus dictyostelium
US5928882A (en) * 1997-10-24 1999-07-27 The Rockefeller University Treatment and prevention of neurodegenerative diseases using modulators of Fe65
AU1536399A (en) * 1997-11-26 1999-06-15 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US6214582B1 (en) * 1998-11-16 2001-04-10 The Research Foundation Of State University Of Ny Y2H35 a strong IKK binding protein

Also Published As

Publication number Publication date
IL151147A0 (en) 2003-04-10
EP1257642B1 (de) 2008-11-26
BR0108247A (pt) 2002-11-05
AU2001235625B2 (en) 2007-01-11
CY1108758T1 (el) 2014-04-09
ES2315273T3 (es) 2009-04-01
NO20023783L (no) 2002-09-09
NO330798B1 (no) 2011-07-18
MXPA02007620A (es) 2002-12-13
PT1257642E (pt) 2009-01-30
EP1257642A1 (de) 2002-11-20
US6696273B2 (en) 2004-02-24
NZ520697A (en) 2005-11-25
WO2001059104A1 (fr) 2001-08-16
KR20020079844A (ko) 2002-10-19
US6942982B2 (en) 2005-09-13
US20040166109A1 (en) 2004-08-26
NO20023783D0 (no) 2002-08-09
US20020061553A1 (en) 2002-05-23
DK1257642T3 (da) 2009-03-30
ATE415476T1 (de) 2008-12-15
CA2399939A1 (fr) 2001-08-16
KR100802687B1 (ko) 2008-02-12
AU3562501A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
BR0207726A (pt) Sais farmacêuticos
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
BR0307702A (pt) Formulações de solução contendo anticorpo
ID28263A (id) DIPEPTIDA OKSAMIL TERMODIFIKASI C-TERMINAL SEBAGAI PENGHAMBAT PADA KELUARGA ICE-ced-3 DARI PROTEASE SISTEINA
DK1372608T3 (da) Medicinske aerosolformuleringer
WO2007002465A3 (en) Stabilizing alkylglycoside compositions and methods thereof
BR0211905A (pt) Dialdeìdos de rapamicina
DOP2001000297A (es) Nuevas imidazotriazinonas sustituidas
DK1521774T3 (da) Trunkerede Tau-proteiner
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ATE291424T1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
BR0007583A (pt) Emprego de 3-(2,4,6-trimetilfenil)-4-neopentilcarbonilóxi-5,5-tetr ametileno-delta3 -dihidrofuran-2-ona para combate das moscas brancas
BR0002441A (pt) Compostos de hidroxidifenil éter
BR0209440A (pt) Sulfonamidas
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
MA27169A1 (fr) Metabolites de l'acide (3-{ [(4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetique
DE60231649D1 (de) Mittel zur behandlung von augentrockenheit und damit zusammenhängenden erkrankungen
BR0209430A (pt) Compostos heterocìclicos
BR0307696A (pt) Composição desodorante ou antitranspirante
ATE313541T1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
ATE311429T1 (de) 8-tetradecenal als duft- oder aromastoff
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida
DE60136688D1 (de) Partnern des ptb1 domäne aus fe65, herstellung und verwendungen davon
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
BR0214524A (pt) 4-cetolactamas e -lactonas 3-bifenil-substituìdas, 3-substituìdas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition